TickerFacts.

Company research / BNR

Burning Rock Biotech Ltd (BNR)

Build a valuation ↗↓ Download CSV

CIK 0001792267 · Nasdaq · Services-Medical Laboratories

  • Sector Services

For the year ended 2025-12-31, Burning Rock Biotech Ltd reported revenue of 539.57M CNY. Revenue grew 4.6% from the prior annual period.

Key ratios (year ended 2025-12-31)

74.7%
Gross margin
-10.2%
Operating margin
-10.3%
Net margin
-10.3%
Return on year-end equity
4.6%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-10

Headquarters locality: Beijing · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue539.57M CNY515.82M CNY537.43M CNY563.24M CNY507.86M CNY429.90M CNY381.68M CNY208.87M CNY
Cost of Revenue136.65M CNY153.42M CNY174.21M CNY183.20M CNY143.72M CNY115.98M CNY108.34M CNY73.81M CNY
Gross Profit402.91M CNY362.40M CNY363.23M CNY380.04M CNY364.15M CNY313.92M CNY273.33M CNY135.06M CNY
R&D Expense166.49M CNY232.29M CNY347.02M CNY421.87M CNY367.86M CNY263.94M CNY156.94M CNY105.30M CNY
Operating Income-54.84M CNY-357.56M CNY-669.32M CNY-980.41M CNY-797.06M CNY-412.40M CNY-169.09M CNY-161.40M CNY
Depreciation & Amortization21.76M CNY52.20M CNY133.40M CNY124.10M CNY47.77M CNY33.31M CNY31.36M CNY24.68M CNY
EBITDA-33.08M CNY-305.36M CNY-535.92M CNY-856.31M CNY-749.30M CNY-379.10M CNY-137.73M CNY-136.72M CNY
Net Income-55.35M CNY-346.63M CNY-653.69M CNY-971.23M CNY-796.70M CNY-407.24M CNY-169.16M CNY-177.50M CNY
Total Assets820.38M CNY885.30M CNY1.04B CNY1.59B CNY2.28B CNY2.66B CNY847.56M CNYn/a
Total Liabilities285.11M CNY304.48M CNY271.59M CNY429.13M CNY433.28M CNY242.02M CNY212.02M CNYn/a
Shareholders' Equity535.26M CNY580.83M CNY768.41M CNY1.16B CNY1.85B CNY2.42B CNY-891.49M CNY-603.46M CNY
Cash & Equivalents478.39M CNY519.85M CNY615.10M CNY905.45M CNY1.43B CNY1.90B CNY94.23M CNY93.34M CNY
Operating Cash Flow-28.44M CNY-92.26M CNY-255.78M CNY-456.81M CNY-477.89M CNY-73.54M CNY-228.04M CNY-148.78M CNY
Capital Expenditures5.25M CNY5.42M CNY8.10M CNY62.03M CNY204.33M CNY60.29M CNY42.97M CNY23.19M CNY
Free Cash Flow-33.69M CNY-97.68M CNY-263.89M CNY-518.84M CNY-682.22M CNY-133.83M CNY-271.01M CNY-171.97M CNY
Share Repurchasesn/an/an/an/a0 CNY0 CNY3.64M CNY0 CNY
Shares Outstandingn/an/an/an/an/an/a25.03Mn/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView